Showing results (11-20 of 115) with videos related to

Sort By:
Pageof 12
Acta Oncologica (Stockholm, Sweden)|August 1, 2015
Changes in the radiological depth correlate with dosimetric deterioration in particle therapy for stage I NSCLC patients under high frequency jet ventilationAlina Santiago, Peter Fritz, Werner Mühlnickel, et al.
Vascular Health and Risk Management|December 4, 2010
Computerized history-taking as a tool to manage dyslipidemiaDavid Zakim, Christine Fritz, Niko Braun, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2004
Prognostic significance of transforming growth factor beta receptor II in estrogen receptor-negative breast cancer patientsMiriam B Buck, Peter Fritz, Juergen Dippon, et al.
Thoracic Surgical Science|February 4, 2011
Carcinoid lung tumors: long-term results from 111 resectionsThomas Kyriss, Sibylle Maier, Stefanie Veit, et al.
Breast Cancer Research and Treatment|November 18, 2008
The promoter C specific ERalpha isoform is associated with tamoxifen outcome in breast cancerSandra Amaral, Werner Schroth, Sibylle Kugler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 8, 2005
Cyclooxygenase-2 expression in human colorectal cancer is unrelated to overall patient survivalRichard Fux, Matthias Schwab, Klaus-Peter Thon, et al.
Archiv Fur Kriminologie|February 17, 2009
[Sudden death in the presence of systemic mastocytosis and urticaria pigmentosa]Frank Wehner, Heinz-Dieter Wehner, Peter Fritz, et al.
International Journal of Radiation Oncology, Biology, Physics|June 9, 2004
External beam radiotherapy fails to prevent restenosis after iliac or femoropopliteal percutaneous transluminal angioplasty: results of a prospective randomized double-blind studyPeter Fritz, Uwe Stein, Christoph Hasslacher, et al.
Physics in Medicine and Biology|February 2, 2017
Dedicated high dose rate <sup>192</sup>Ir brachytherapy radiation fields for in vitro cell exposures at variable source-target cell distances: killing of mammalian cells depends on temporal dose rate fluctuationCornelia Veigel, Günther H Hartmann, Peter Fritz, et al.
Journal of Leukocyte Biology|January 4, 2007
Attenuated induction of epithelial and leukocyte serine antiproteases elafin and secretory leukocyte protease inhibitor in Crohn's diseaseMichael Schmid, Klaus Fellermann, Peter Fritz, et al.
Pageof 12